Board Member
AEON Biopharma, Inc. (AEON)Equibles does not estimate personal net worth.
Marc Forth is recorded as CFO at AEON Biopharma, Inc. (AEON) since May 17, 2024 and CEO and Board Member at AEON Biopharma, Inc. (AEON) since July 27, 2023. AEON Biopharma, Inc. reported in an 8-K filed March 27, 2025 that Marc Forth resigned as President and Chief Executive Officer, effective April 4, 2025. AEON Biopharma, Inc. reported in an 8-K filed May 16, 2024 that Marc Forth was appointed principal financial officer, effective May 17, 2024. AEON Biopharma, Inc. reported in an 8-K filed July 27, 2023 that Marc Forth was appointed Chief Executive Officer and principal executive officer. Equibles holds 5 filed executive changes naming Marc Forth; each is listed under recent activity with its source filing. The proxy statement of AEON Biopharma, Inc. reports total compensation of $135,616 for Marc Forth in fiscal 2025, including a base salary of $135,616. Disclosed compensation is on record for 4 fiscal years. AEON Biopharma, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at AEON Biopharma, Inc. includes Jost Fischer (CEO, Chairman and Board Member), Robert Bancroft (CEO and Board Member), John Bencich (CFO) and 7 others.
“On March 24, 2025, AEON Biopharma, Inc. (the "Company" or "AEON") was notified by Marc Forth that he intended to resign as the Company's President and Chief Executive Officer ("CEO") in order to pursue another opportunity.”
“On May 16, 2024, our Board of Directors appointed Marc Forth, age 53, as our principal financial officer, effective as of May 17, 2024.”
2024-05-17–present
2023-07-27–present
2023-07-27–present
2023-07-27–2025-04-04
AEON
Biotechnology · Healthcare
CFO, CEO, Board Member
2023-07-27–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | AEON Biopharma, Inc. (AEON) | Former President and Chief Executive Officer | $135,616 | $135,616 |
| 2024 | AEON Biopharma, Inc. (AEON) | Former President and Chief Executive Officer | $550,000 | $5,044,599 |
| 2023 | AEON Biopharma, Inc. (AEON) | Former President and Chief Executive Officer | $550,000 | $3,982,378 |
| 2022 | AEON Biopharma, Inc. (AEON) | President and Chief Executive Officer | $550,000 | $4,804,637 |
